FindTrial
Sign In

Leptin,adiponectin and ghrelin levels in normal,overweight and obese individuals

Evaluation of role of fasting serum levels of Leptin,Adiponectin and Ghrelin in normal,overweight and obese individuals

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/01/022782
Enrollment
86
Registered
2020-01-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E669- Obesity, unspecified Health Condition 2: E669- Obesity, unspecified

Interventions

None listed

Sponsors

KASTURBA MEDICAL COLLEGE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All individuals after informed consent between age 18 and 50 years are grouped into normal, overweight and obese subjects based on BMI(WHO ASIA PACIFIC GUIDELINES) after the exclusion criteria

Exclusion criteria

Exclusion criteria: Patient less than 18 years and more than 50 years of age Pregnancy Oedematous state due to any cause Organ failures(liver, kidney, heart and lung) Hypothyroidism, Diabetes mellitus,hypertension, dyslipidemia On treatment with thiazides,lipid-lowering agents and glucocorticoids Any acute illness Chronic diseases like TB, HIV and CTD

Design outcomes

Primary

MeasureTime frame
Levels of leptin,adiponectin and ghrelin in normal,overweight and obese subjects Anthropometric measurements in the normal,overweight and obese individuals along with body mass indexTimepoint: ONE YEAR—

Secondary

MeasureTime frame
Leptin,adiponectin and ghrelin levels correlation with the biochemical,anthropometric and clinical variables in obese individuals compared to normal and overweight individualsTimepoint: ONE YEAR—

Countries

India

Contacts

Public ContactTShanti priya

kasturba medical college

ravi.katte@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026